Humedix Co Ltd
Company Profile
Business description
Humedix Co Ltd is a cosmeceutical healthcare company. It supplies Hyaluronic Acid raw material medicine of low molecule and the high molecule which are used in arthritis medicine, eyedrops and in injections for ophthalmology. Further, it is dedicated to the development of new functional materials with diverse physiological activities including vitamin derivatives and supplies a variety of functional materials. In addition, it offers various medical devices, cosmetic and health functional foods. The business activities are primarily carried out through South Korea.
Contact
No 603,17, Chang-eop-ro
6th Floor, A-dong, Pangyo I Square
Sujeong-gu
Seongnam-si
AnyangGyeonggi431-809
KORT: +82 7074925600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
386
Stocks News & Analysis
stocks
Investors overlooking ASX share’s potential
stocks
Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy
stocks
What did Morningstar subscribers buy and sell in April?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,870.60 | 46.70 | -0.52% |
| CAC 40 | 7,952.55 | 129.72 | -1.61% |
| DAX 40 | 23,950.57 | 505.69 | -2.07% |
| Dow JONES (US) | 49,526.17 | 537.29 | -1.07% |
| FTSE 100 | 10,195.37 | 177.56 | -1.71% |
| HKSE | 25,962.73 | 426.31 | -1.62% |
| NASDAQ | 26,225.14 | 410.08 | -1.54% |
| Nikkei 225 | 61,409.29 | 1,244.76 | -1.99% |
| NZX 50 Index | 12,965.01 | 60.06 | -0.46% |
| S&P 500 | 7,408.50 | 92.74 | -1.24% |
| S&P/ASX 200 | 8,630.80 | 42.70 | -0.49% |
| SSE Composite Index | 4,135.39 | 42.53 | -1.02% |